文献速递慢性肾脏病血液净化与透析

植酸在慢性肾脏病治疗中的相关性

The Relevance of Phytate for the Treatment of Chronic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-08-07

本文综述植酸的结构及其对慢性肾脏病患者的多重潜在作用。植酸可结合并减少肠道对磷酸盐及铁、锌、钙、镁等矿物质的吸收;维持性血透患者静脉给予植酸可能减少羟基磷灰石形成、血管钙化和钙化防御。口服植酸或体外研究提示其可能减少骨质疏松、尿钙结石和牙菌斑,并具抗炎抗氧化效应,但尚需确证性临床试验。

要点

  • 植酸可减少肠道磷酸盐及铁、锌、钙、镁的吸收。
  • 血透患者静脉植酸可能减少血管钙化和钙化防御。
  • 植酸抗炎抗氧化部分源于其螯合铁的能力。

核心结论

  • 植酸对CKD患者具有多种潜在治疗作用,但需确证性临床试验验证。

研究设计与样本

  • 本文为综述,总结植酸的结构及其对CKD患者的潜在效应。

主要发现

  • 植酸可紧密结合并减少肠道对磷酸盐及铁、锌、钙、镁等宏量和微量元素的吸收。
  • 人体肠道缺乏植酸酶,植酸在小肠基本不被降解,仅少量被吸收,而与磷酸盐结合的植酸吸收更差。
  • 维持性血透患者的临床试验表明,静脉给予植酸可能减少羟基磷灰石形成、血管钙化和钙化防御。
  • 口服植酸或体外研究提示植酸可能减少骨质疏松、尿钙结石形成和牙菌斑形成。
  • 植酸似乎具有抗炎和抗氧化效应,至少部分源于其螯合铁的能力。

临床怎么用

  • 对CKD患者推荐植物性饮食时,需考虑植酸减少磷酸盐及铁、锌、钙、镁吸收的潜在影响。
  • 维持性血透患者静脉给予植酸的潜在获益尚属研究性,不作为常规临床推荐。

局限性

  • 植酸对癌症抑制、认知衰退、神经退行性疾病及胃肠代谢紊乱的潜在作用仅基于细胞、动物研究或人类观察性研究,未获确证。
  • 植酸在CKD患者中的治疗获益尚缺乏确证性临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diets high in plant-based foods are commonly recommended for people with CKD. One putative advantage of these diets is reduced intestinal phosphate absorption. This effect has been ascribed to phytic acid (myoinositol hexaphosphoric acid) and its anion, phytate, that are present in many plant foods, particularly in the seeds, nuts, grains, and fruits of plants. This article reviews the structure and many actions of phytate with particular reference to its potential effects on people with CKD. Phytate binds avidly to and can reduce gastrointestinal absorption of the phosphate anion and many macrominerals and trace elements including iron, zinc, calcium, and magnesium. This has led some opinion leaders to label phytate as an anti-nutrient. The human intestine lacks phytase; hence, phytate is essentially not degraded in the small intestine. A small amount of phytate is absorbed from the small intestine, although phytate bound to phosphate is poorly absorbed. Clinical trials in maintenance hemodialysis patients indicate that intravenously administered phytate may decrease hydroxyapatite formation, vascular calcification, and calciphylaxis. Orally administered phytate or in vitro studies indicate that phytate may also reduce osteoporosis, urinary calcium calculi formation, and dental plaque formation. Phytate seems to have anti-inflammatory and antioxidant effects, at least partly because of its ability to chelate iron. Other potential therapeutic roles for phytate, not definitively established, include suppression of cancer formation, reduction in cognitive decline that occurs with aging, and amelioration of certain neurodegenerative diseases and several gastrointestinal and metabolic disorders. These latter potential benefits of phytate are supported by cell or animal research or observational studies in humans. Many of the above disorders are particularly common in patients with CKD. Definitive clinical trials to identify potential therapeutic benefits of phytate in patients with CKD are clearly warranted.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ekramzadeh M, Kalantar-Zadeh K, Kopple JD, et al. The Relevance of Phytate for the Treatment of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2024. PMID: 39110986. doi:10.2215/CJN.0000000000000558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。